Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiyean Nam

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Topics in Medicinal Chemistry|September 17, 2009
Steroid hormone binding receptors: application of homology modeling, induced fit docking, and molecular dynamics to study structure-function relationshipsWendy Cornell, Kiyean Nam
Proteins|July 29, 2004
Structural components of SCAN-domain dimerizationsKiyean Nam, Christian Honer, Christoph Schumacher
Proteins|May 18, 2006
Dynamic control of allosteric antagonism of leukocyte function antigen-1 and intercellular adhesion molecule-1 interactionKiyean Nam, Vladimir Maiorov, Bradley Feuston, et al.
Biopolymers|February 13, 2003
Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor alpha and estrogen-related receptor gammaKiyean Nam, Paul Marshall, Romain M Wolf, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 11, 2023
Novel modeling approach integrating population pharmacokinetics and interspecies scaling to predict human pharmacokinetics of the new anti-tuberculosis agent telacebec (Q203)Jeongjun Kim, Tae Hwan Kim, Jinho Choi, et al.
Journal of Chemical Information and Modeling|July 31, 2009
QSAR models for predicting the similarity in binding profiles for pairs of protein kinases and the variation of models between experimental data setsRobert P Sheridan, Kiyean Nam, Vladimir N Maiorov, et al.
Cancers|October 14, 2022
A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor MicroenvironmentYeejin Jeon, Hwankyu Kang, Yeongin Yang, et al.
European Journal of Medicinal Chemistry|October 18, 2016
Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203Sunhee Kang, Young Mi Kim, Ryang Yeo Kim, et al.
Molecular Pharmacology|April 16, 2003
Glucocorticoid receptor antagonism by cyproterone acetate and RU486Christian Honer, Kiyean Nam, Cynthia Fink, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2006
p38 MAP kinase inhibitors. Part 6: 2-arylpyridazin-3-ones as templates for inhibitor designSwaminathan R Natarajan, Stephen T Heller, Kiyean Nam, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|September 17, 2009
Steroid hormone binding receptors: application of homology modeling, induced fit docking, and molecular dynamics to study structure-function relationshipsWendy Cornell, Kiyean Nam
Proteins|July 29, 2004
Structural components of SCAN-domain dimerizationsKiyean Nam, Christian Honer, Christoph Schumacher
Proteins|May 18, 2006
Dynamic control of allosteric antagonism of leukocyte function antigen-1 and intercellular adhesion molecule-1 interactionKiyean Nam, Vladimir Maiorov, Bradley Feuston, et al.
Biopolymers|February 13, 2003
Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor alpha and estrogen-related receptor gammaKiyean Nam, Paul Marshall, Romain M Wolf, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 11, 2023
Novel modeling approach integrating population pharmacokinetics and interspecies scaling to predict human pharmacokinetics of the new anti-tuberculosis agent telacebec (Q203)Jeongjun Kim, Tae Hwan Kim, Jinho Choi, et al.
Journal of Chemical Information and Modeling|July 31, 2009
QSAR models for predicting the similarity in binding profiles for pairs of protein kinases and the variation of models between experimental data setsRobert P Sheridan, Kiyean Nam, Vladimir N Maiorov, et al.
Cancers|October 14, 2022
A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor MicroenvironmentYeejin Jeon, Hwankyu Kang, Yeongin Yang, et al.
European Journal of Medicinal Chemistry|October 18, 2016
Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203Sunhee Kang, Young Mi Kim, Ryang Yeo Kim, et al.
Molecular Pharmacology|April 16, 2003
Glucocorticoid receptor antagonism by cyproterone acetate and RU486Christian Honer, Kiyean Nam, Cynthia Fink, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2006
p38 MAP kinase inhibitors. Part 6: 2-arylpyridazin-3-ones as templates for inhibitor designSwaminathan R Natarajan, Stephen T Heller, Kiyean Nam, et al.
Pageof 2